Your access and use of the Website, is conditional upon your acceptance and compliance with the terms, conditions, notices and disclaimers contained in these terms of use, in our Privacy Policy and elsewhere on the Website (known collectively as the Terms of Use).

This Website is designed to provide information about diabetes to Australian healthcare professionals. By using the Website, you acknowledge that the information, news and tools provided on the Website are not a substitute for professional medical advice. The function of this Website is to provide healthcare professionals accredited education (such as the RACGP or similar) and is not intended to diagnose or treat any health problem or disease.

By accessing the Website, you agree to these Terms of Use. If you do not accept the Terms of Use, you must cease accessing the Website immediately.

The aim of the Website is to introduce you to the activities of Novo Nordisk. The Website is available for your information, interest and education. The following Terms of Use, as may be amended from time to time, shall apply to any and all access to the Website and to all use of the Website and its content.

2. Links Disclaimer

Linked sites are not under the control of Novo Nordisk and Novo Nordisk isn’t responsible for the content of any linked site or any link contained in a linked site, or any changes or updates to such sites. These links are provided as a convenience, and the inclusion of any link does not imply endorsement by Novo Nordisk.

3. Legal Disclaimer

Novo Nordisk disclaims any and all liability related to or arising out of use of the information contained in this site.

Changes to the site

Novo Nordisk reserves the right to make improvements or change information, services, products and or other materials on the site at any time without notice.

The Changing Diabetes Map is an interactive web-based tool which displays summarised average HbA1c data from different geographic regions within Australia. The HbA1c data is accessed through the "Mapping Glycaemic Control Across Australia" project, which collects national HbA1cdata. This project addresses the need for HbA1c data which has previously been lacking in the primary care setting.

The "Mapping Glycaemic Control Across Australia" project has been possible through the unrestricted funding support and partnership of Novo Nordisk, and the support and assistance of Sullivan Nicolaides Pathology, Central Queensland Pathology Laboratory, Barratt & Smith Pathology, Douglas Hanly Moir Pathology, Southern.IML Pathology, Capital Pathology, Melbourne Pathology, Hobart Pathology, Launceston Pathology, North West Pathology, Clinpath Laboratories, QML and Western Diagnostic Pathology.

The Changing Diabetes® Map allows for the observation of trends and no statistical conclusion can be drawn. The intent of providing this material is informational and not as advice.

The information you are about to access may not comply with the Australian or New Zealand regulatory environment.

Do you still want to proceed?

You are about to leave www.changingdiabetes.com.au.

The information you are about to access may not comply with the Australian regulatory environment. Please review the Approved Product Information to understand the terms of a product’s registration in Australia. For further information relevant to the Australian environment, please contact Novo Nordisk. The linked information is educational only and not intended as advice. Any information provided should be discussed with a healthcare professional and does not replace their advice.

Do you still want to leave www.changingdiabetes.com.au?

Privacy policy

Privacy Policy Australia and New Zealand

Introduction

Novo Nordisk Pharmaceuticals Pty Ltd (ABN 40 002 879 996) and Novo Nordisk Pharmaceuticals Limited (Company No. 481 264) (collectively “Novo Nordisk”) respect and uphold your rights to privacy protection under: the Privacy Act 1988 (Cth); the Privacy Regulations 2013 (Cth); Australian State and Territorial laws governing the use of personal information or health records; the Privacy Act 1993 (New Zealand); New Zealand privacy legislation governing the management of clinical and health information; and, the general law intended to protect your privacy - as amended from time to time. Novo Nordisk is required to comply with the privacy principles that regulate the handling of personal information which are the Australian Privacy Principles in Australia and the New Zealand Privacy Principles in New Zealand (collectively the “Privacy Principles”). In addition to this Privacy Policy, we may on occasion provide you with specific notice about how we use particular information we collect from you.

This Policy details the practices we have adopted to protect your privacy, so that you can feel confident about how we manage the personal information you entrust to us. This policy should be read in conjunction with our Terms of Use. Keeping user identifiable information secure is a priority for Novo Nordisk. By providing personal information and/or continuing to engage with Novo Nordisk you consent to your personal information being collected, used and disclosed in accordance with this Privacy Policy. Should you wish to withdraw your consent, please refer to the ‘Review, Change and Correction of Personal Information’ section below.

Novo Nordisk believes that choice is one of the most important privacy principles. You will always have a choice as to what information you provide and we will give you the right to be anonymous in your dealings with us wherever possible. However, if you decide to withhold personal information which is necessary for us to provide a product or service, it may affect our ability to provide you with that product or service.

What information does Novo Nordisk collect about you?

The information we collect about you will vary depending upon our dealings with you, however Novo Nordisk will only ask for information where there is a clear need and it is reasonably necessary for our functions or activities.

Generally, Novo Nordisk collects information for one or more of the following purposes:

As required by law, collecting, storing and processing reports of adverse events experienced by patients using a Novo Nordisk product. Adverse event information may be transferred to affiliated companies of Novo Nordisk which may be located overseas for the purposes of processing and reporting the adverse event to the respective health authorities as required by law. We may also use that information to contact you in relation to your report or send you product, health or other information which we consider relevant;

Supplying you with clinical samples of our products;

Sending you material on our activities and products or developments in pharmaceutical treatments which may be of interest to you and tailoring marketing services to suit your needs;

Administering disease awareness/management programs or other similar programs organised by us, which you have agreed to participate in, or be involved with;

Helping us analyse traffic patterns throughout our website;

Notifying you of matters required by law (such as product recalls);

Managing, planning and arranging meetings between you and Novo Nordisk’s sales representatives;

Reporting obligations under Medicines Australia’s then current Code of Conduct.

Monitoring our conduct with respect to other regulations or professional conduct and integrity codes;

Market research;

Conducting due diligence with respect to our service providers;

Notifying you of third party products that we believe may interest you;

Clinical trials or other research administration in which you have agreed to participate or be involved with.

In addition, Novo Nordisk may gather information about you automatically through your use of our website (e.g. your Internet Protocol (“IP”) address) and how you navigate our website. See also the sections below on “Using our Website” and “About Cookies”.

We will usually only collect your personal information from you or an authorised representative.

Some websites that have links on our website may collect personally identifiable information about you when you access or utilise those links. We do not control the collection or use of such information, and the practices of those websites are not covered by this Privacy Policy.

Use and disclosure of your personal information

Novo Nordisk will only use personal information for purposes which are directly related to one of our business functions or activities and for: the primary purpose for which it was given to us; or, to the extent:

Indicated to you at the time of supply of the information to us;

You consented to a secondary use or disclosure;

You would reasonable expect it to be used at the time of supplying the information to a third party or a publicly available source;

Required to provide you with a service or goods which you have requested or which relate to those goods or services;

Required for the ordinary operation of our website or our business (e.g. to send you information about our goods and services) ;

Required or permitted by law or regulatory practice;

Expressly permitted under any agreement with you; or

To lessen a serious threat to a person’s health or safety.

As a general practice , we require that Novo Nordisk’s third party service providers who handle and obtain personal information comply with: this Policy; the relevant Australian and New Zealand Acts and Regulations (as amended from time to time) – and are subject to obligations to treat this information as confidential information.

We do not sell, rent, or trade your personal information with others. Information provided by you may be stored in databases or other systems which are stored overseas including, but not limited to Australia, New Zealand, Denmark and India.

Novo Nordisk may transfer your de-identified personal and health information to an associated company in USA and/or Europe for the specific purpose of reporting adverse events. We will ensure we comply with our obligations under the respective Privacy Principles with respect to that transfer.

We impose obligations on any external organisations with which we share your personal information to maintain the integrity and security of that information.

We may disclose your personal information in the following circumstances:

Where it is required or authorised by law

When one or more of our business partners, co-sponsors a service, promotion and/or contest, we may share some or all of the information collected in connection with such a service, promotion and/or contest

To our agents, contractors or third party service providers that provide financial, administrative or other services in connection with the operation of our business, e.g. financial or legal advisers, mailing houses - some of which may be located outside Australia

We disclose aggregate data, statistical analyses or demographics relating to users of our website (you cannot be identified from this information), and

To our parent company located in Denmark for the purpose of administration, safety monitoring of products and to enable us to provide you with better service.

Forms used to collect your information may give more specific details about the way we use your information.

Security of your personal information

We take all reasonable steps to protect your personal information from misuse, loss, unauthorised access, modification or disclosure. Your information is stored securely whether in an electronic or physical form. For example, only staff needing access to the information are allowed access. Your personal information is stored in secured premises or in electronic databases requiring logins and passwords.

Some information is kept for a number of years to comply with legal requirements. Any personal information that is no longer needed is de-identified or destroyed.

Links ­

Some resources can be accessed with links from www.novonordisk.com.au and www.novonordisk.co.nz and these links are not maintained by Novo Nordisk and therefore are not subject to Novo Nordisk’s Privacy Policy. Novo Nordisk is not responsible for the content of any such resources. We do not control the collection and use of such information or the practices of those websites. The existence of a link should not be assumed as an endorsement by Novo Nordisk of the content of the linked page.

Government identifiers

In our dealings involving some consumers we use a unique "H" number assigned by the Australian Department of Health and Ageing to each government-approved patient who receives human growth hormone. We are required to use and disclose the H number consistently with the relevant legislative requirements (contained in the National Health (Growth Hormone Program) Special Arrangement issued under the National Health Act) in our capacity as a "responsible person" under those arrangements.

Changes to our Privacy Policy

From time to time, we may change our Privacy Policy. We will post those changes on our website so that our customers will always be aware of what information we collect, how we use it, and under what circumstances we share the information with others. Our website is located at www.novonordisk.com.au or www.novonordisk.co.nz.

Using our website

We collect general usage information about visitors coming to our website. This includes:

The date and time you access our website

Which parts within a Novo Nordisk website you visited, and

If you linked to the Novo Nordisk website from another website, the address of that website.

You cannot be identified from this information.

About cookies

Sometimes our web servers collect this general information (referred to above) with the help of cookies. A cookie is a small file that a Web site writes to your hard drive when you visit that website. Cookies cannot read information from your hard drive or read information from other cookies.

Review, change, and correction of personal information

You can always seek access to your personal information and ask us to correct or delete any inaccurate, incomplete or out of date information. Contact us at the contact address below if you want access to, or want to correct, or make a complaint in relation to the personal information we hold about you. One of our representatives will contact you in relation to your request or complaint.

We are required to take reasonable steps to correct information we hold, to ensure it is accurate, up to date, relevant and not misleading, having regard for the purposes for which it is held.

We are required to take reasonable steps to correct faulty information:

Where we are satisfied, independently of any request, that the personal information we hold is faulty; or,

Where an individual requests we correct their personal information.

There is no fee for requesting access to your information. However, we may charge you the reasonable cost of processing your request and there may be some legal or administrative reasons to deny access. If we decide to deny access, we will provide you with a reason why.

You may review, change, or correct any personal information including the permitted uses of your personal information by contacting Novo Nordisk at the relevant address below.

Contact details

If you have any questions, concerns or complaints about our privacy policy or practices please contact us:

Disclaimer:

Novo Nordisk disclaims any and all liability related to or arising out of use of the information contained in this website.

Terms of use

Welcome to the Changing Diabetes Website.

Important: please read these terms of use before accessing or using this website.

Your use of this website and the information available on this website is subject to the following terms and conditions. By accessing or using this website you acknowledge that you have read, understood and agreed to these terms of use, as updated by Novo Nordisk from time to time. Novo Nordisk may modify these terms of use at any time and such modifications shall be deemed effective immediately upon posting on this website.

Since your continued use of this website shall be deemed acceptance of any current posted terms of use, you should periodically visit this page to review the current terms of use.

The information provided on this website is for general information and educational purposes only. This website may, from time to time, contain information relating to various medical conditions and their treatment. The product related information on this website is not medical advice and should not be relied upon by any particular individual or for any specific purpose. Any medical questions should be referred to your healthcare professional. It is important that you rely only on the advice of a health care professional to advise you on your specific situation.

Restrictions on use

This website is available only for your personal, non-commercial use. You may not copy, reproduce, republish, post, distribute, transmit or modify in any way all or any part of this website.

All copyright and other proprietary notices contained in downloaded materials must be preserved and retained. All contents of this website are copyrighted work of Novo Nordisk and/or any of Novo Nordisk's suppliers or affiliates unless otherwise noted, and may not be used without the express written permission of Novo Nordisk or except as provided herein.

Images of people or places displayed on this website are either the property of, or used with permission by, Novo Nordisk. The use of these images by you is strictly prohibited.

Disclaimer and limitation of liability

Novo Nordisk offers products and services to diagnose, prevent and treat disease. Our prescription medicines for use by healthcare professionals are regulated by government agencies in each of the countries in which we do business, such as: the Therapeutic Goods Administration in Australia; Medsafe (the New Zealand Medicines and Medical Devices Safety Authority); and, the Food and Drug Administration in the United States. Regulations often restrict the prescribing information that can be disclosed to the public thus requiring personal consultation with your healthcare professional.

Under no circumstances will Novo Nordisk or any other company within the Novo Nordisk Group of Companies be liable for any indirect, incidental, special and/or consequential damage or loss of profits which result from any use or access of, or any inability to use or access, this website or any content.

Privacy Policy

Novo Nordisk respects the privacy of its users and has created a Privacy Policy that explains how it handles the personal information of the users of this website and their rights and responsibilities with respect to personal information disclosed on this website. To read our Privacy Policy, please click here: www.novonordisk.com.au. By providing any personal information to Novo Nordisk through this website, you acknowledge that you have read and consented to the terms of Novo Nordisk's Privacy Policy.

Indemnification

You agree to indemnify, defend and hold harmless Novo Nordisk, its officers, directors, employees, agents, suppliers and third party partners from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of these terms of use (including through negligent or wrongful conduct) by you.

Personal information collection

Novo Nordisk collects personally identifiable information (i.e. information from which you can be identified, such as name, address, telephone number or e-mail address) only when it is asked for and/or you voluntarily submit it to us. While you do not have to provide this information a failure to do so may mean that we are unable to provide you with information or services from this website.

Any such information will be dealt with in accordance with our Privacy Policy. Amongst other things the Privacy Policy sets out how you can access and correct the personal information we may hold about you, or complain about our handling of your personal information.

The purpose for which the information is collected will either be made clear to you at the time the information is provided by you or collected from you, or will otherwise be in accordance with our Privacy Policy.

Jurisdictional issues/export restrictions

This website is controlled and operated by Novo Nordisk from its offices within the State of New South Wales, Australia. Although the internet is global in nature, the laws regulating the manner in which pharmaceutical companies convey medical or product information is not. Each country has its own set of rules, regulations and laws. As a result, information intended for dissemination in a particular country may not be appropriate for use outside that country. The information on this website is designed to comply with the laws of Australia. The information on this website is intended for access and use by Australian residents only. These terms of use shall be governed by and construed in accordance with the laws of the State of New South Wales, without giving effect to any principles of conflicts of law. If any provision of these terms of use shall be unlawful, void, or for any reason unenforceable, then that provision shall be deemed severable from these terms of use and shall not affect the validity and enforceability of any remaining provisions.

This website may link to other websites, some of which are outside Australia. Those websites may have information that is appropriate only to the particular originating country or region where the website is based. You should not construe anything on this website as a promotion or solicitation for any product or for the use of any product that is not authorised by the laws and regulations of the country where you are located. Novo Nordisk makes no representation that materials in this website are appropriate or available for use in other locations. Those who choose to access this website from other locations do so on their own initiative and are responsible for compliance with local laws, if and to the extent local laws are applicable.

Software from this website is further subject to United States export controls. No software from this website may be downloaded or otherwise exported or re-exported (i) into (or to a national or resident of) Cuba, Iraq, Libya, North Korea, Iran, Syria or any other country subject to United States export control restrictions; or (ii) to anyone on the U.S. Treasury Department’s list of Specially Designated Nationals or the U.S. Commerce Department’s Table of Denial Orders. By downloading or using the Software, you represent and warrant that you are not located in, under the control of, or a national or resident of any such country or on any such list.

You agree that you will not use any robot, spider or other automatic or manual process or device to “Screen scrape”, monitor, “mine”, or copy web pages of this website, or the content contained therein, without Novo Nordisk’s express consent. You also agree that you will not use any device, software or routine in an attempt to interfere with the proper operation of this website. You will not spam any user of this website for any reason. You will not do anything that puts an unreasonably large load on Novo Nordisk’s infrastructure. Any access or attempt to access other areas of Novo Nordisk’s computer system, or any information on its systems is strictly prohibited.

General information collection

Novo Nordisk collects non-personally identifiable information in aggregate form to track data such as the total number of visits to our website, the number of visitors to each page of our website, the general geographical areas from where those visitors accessed our website and the domain names of our visitors' internet service providers. We use this information, which remains in aggregate form, to understand how our visitors use our website so that we may improve them and the services we offer. We may also share this information with other companies within the Novo Nordisk group and with other third parties. No personally identifiable information is disclosed in this process.

Use of IP addresses

An Internet Protocol (IP) address is a set of numbers that is automatically assigned to your computer whenever you log on to your internet service provider or through your organisation's local area network (LAN) or wide area network (WAN). Web servers automatically identify your computer by the IP address assigned to it during your session online.

Novo Nordisk, or third party companies acting on behalf of Novo Nordisk, may collect IP addresses for the purposes of systems administration and to audit the use of our website. We do not ordinarily link a user's IP address to personally identifiable information of that user, which means each user's session will be logged, but the user remains anonymous to us. However, we may use IP addresses to identify users of our website when we feel it is necessary to enforce compliance with this website's terms of use, or to protect our service, website or other users.

No endorsement

Certain links on this website lead to resources located on servers that are not maintained by Novo Nordisk or under its control. We provide such links merely for our users' convenience. Novo Nordisk is not responsible for the content of any such referenced websites or for the availability of access to such websites. Inclusion on this website of any link to another website, or any reference to any product or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply an endorsement or recommendation of such by Novo Nordisk. Access to other websites linked to this website is at your own risk, and to the extent permitted by law we disclaim all liability with regard to your access to such linked websites.

Termination

The terms of use are effective until terminated by Novo Nordisk. Novo Nordisk may terminate these terms of use and your access to this website at any time without notice. In the event of termination, you are no longer authorised to access this website. All restrictions imposed on you, disclaimers and limitations or liability set out in these terms of use will survive termination.

Governing law

These terms of use are governed by and construed in accordance with the laws of New South Wales, Australia. You irrevocably and unconditionally submit to the non-exclusive jurisdiction of the courts of New South Wales.

Miscellaneous

If any provision of these terms of use is found to be invalid or unenforceable by a court of law, such invalidity or unenforceability will not affect the remainder of these terms of use which will continue in full force and effect. All rights not expressly granted are reserved.